What is ADVB stock price today?

ADVB (Advanced Biomed Inc) stock is trading at $4.15 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is ADVB stock going up or down today?

ADVB stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ADVB stock now?

The decision to buy ADVB depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ADVB a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ADVB based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ADVB stock overvalued or undervalued?

ADVB currently trades at a P/E ratio of 1.18, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if ADVB is fairly priced.

What is ADVB's P/E ratio?

ADVB has a price-to-earnings (P/E) ratio of 1.18, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is ADVB's market cap?

ADVB (Advanced Biomed Inc) has a market capitalization of $0.01 billion, making it a small-cap stock.

What is ADVB's price to book ratio?

ADVB trades at a price-to-book (P/B) ratio of 0.58, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does ADVB pay dividends?

ADVB does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ADVB's dividend yield?

ADVB does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ADVB stock a good long-term investment?

ADVB's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ADVB's revenue growth rate?

Revenue growth data for ADVB is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ADVB are available on our dashboard with complete income statement analysis.

What are the risks of investing in ADVB?

Key risks for ADVB include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ADVB compare to its competitors?

Compare ADVB to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ADVB's performance and positioning.

What is ADVB's stock price target for 2026?

Our AI model provides price targets for ADVB based on fundamental analysis: Bull case $5.40 (+30%), Base case $4.77 (+15%), Bear case $3.74 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about ADVB?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ADVB. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ADVB's next earnings report?

ADVB reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ADVB - Advanced Biomed Inc

NYSE * Health Care * Health Care Equipment & Supplies

$4.15

+$0.09 (+2.16%)

About Advanced Biomed Inc

Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, an automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagulable state samples of tumor patients; A+SCDrop, a circulating tumor cell (CTC) single-cell capture device; and A+CellScan, an analyzer with an immunostaining chip for immunostaining/analysis of the AC-1000 product. The company also offers microfluidic biochips, such as A+Pre, AC-1000 CTC enrichment, and A+CellScan chips to provide assay products and services to cancer patients. In addition, its immunochromogenic kits include A+CTCE kit to identify epithelial circulating tumor cells and determined by the immunochromogenicity of EpCAM, CK (pan), CD45, and CD14 antibodies; A+CTCM kit to identify mesenchymal circulating tumor cells based on the immunochromogenicity of Vimentin, CD45, and CD14 antibodies; A+EMT to identify epithelial-to-mesenchymal circulating tumor cells determined by the immunochromogenicity of cell-surface Vimentin, and CD45 and CD14 antibodies; and A+CM to identify tumor-associated macrophages based on the immunochromogenicity of PD-L1, CD45, and CD14 antibodies. Further, the company is developing A+LCGuard for early screening of lung cancer. Additionally, it establishes and operates medical clinics in the People's Republic of China. The company was founded in 2014 and is headquartered in New York, New York.

ADVB Key Statistics

Market Cap

$5.66M

P/E Ratio

1.18

P/B Ratio

0.58

EPS

$3.52

Employees

How ADVB Compares to Peers

ADVB has the lowest P/E ratio in Health Care Equipment & Supplies, suggesting it may be the most undervalued

ADVB is the smallest among peers, which may offer higher growth potential

P/E Rank

of 2

Margin Rank

N/A

of 1

Growth Rank

N/A

of 1

Size Rank

of 2

Company	Market Cap	P/E	Growth	Margin	Compare
ADVB(This stock)	$5.66M	1.2	0%	0.0%	-
AMZNAmazon Com	$2.29T	30.6	0%	0.1%	vs AMZN

Advanced Biomed Inc Company Information

Headquarters: Nevada; U.S.A
Website: www.advanbiomed.com
Sector: Health Care
Industry: Health Care Equipment & Supplies

ADVB - Advanced Biomed Inc

About Advanced Biomed Inc

ADVB Key Statistics

How ADVB Compares to Peers

Advanced Biomed Inc Company Information

ADVB Lician Score

ADVB Financial Snowflake

Upcoming Events for ADVB